Bioactivity:

Evogliptin(DA-1229) is a potent and selective DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor) that can improve insulin resistance and delays the onset of diabetes. Evogliptin delays the onset of diabetes in young db/db mice and improves insulin sensitiv

CAS nr:

1246960-27-9

Purity:

98%

Molecular Weight:

437,89

SMILES:

O=C1NCCN(C(C[C@H](N)CC2=CC(F)=C(F)C=C2F)=O)[C@@H]1COC(C)(C)C.[H]Cl

Formula:

C19H27ClF3N3O3

Pathway:

Target: